Peptide Supplier Vetting Checklist
A peptide supplier vetting checklist should build a dated file, not a trust score. The file should name the legal seller and maker. It should also name the shipper and lab. It should link each claim to an item, sample, lot, method, criterion, result, and source. It should also compare the paper file with what arrives. A polished site, lab logo, certificate, or public listing cannot close all of those checks. This guide uses neutral states such as VERIFIED, OBSERVED, UNKNOWN, CONFLICT, and HOLD. None of those states promises supplier quality, product identity, purity, safety, approval, or legal status.
Start with a neutral review record
Open one record for the exact supplier and site. Do not begin with a score. A score can hide a key gap behind many easy checks.
Use these evidence states:
| State | Meaning |
|---|---|
| ASSERTED | The supplier made the claim |
| OBSERVED | The reviewer saw the page, file, or item |
| VERIFIED | An independent named source matched the fact |
| UNKNOWN | The fact is missing or cannot be checked |
| CONFLICT | Two records do not agree |
| HOLD | The team paused reliance or spend pending review |
These states describe the review file. VERIFIED does not mean trusted for all purposes. It means one named fact matched one source on one date.
Keep official sources within scope
The WHO model certificate of analysis is for quality control labs and pharmaceutical materials in its stated context. The WHO model lists the lab and request source. It also lists the sample, batch, and maker. The model includes methods, criteria, results, and approval. It is a useful document model. It does not prove that any supplier file is true.
The ILAC accredited body page sends users to the relevant accreditation body to check a lab and its current scope. ILAC says the accreditation body can confirm status and scope. An ILAC signatory result does not prove a specific report, sample, lot, method, or item result.
The FDA approval explainer says FDA does not approve laboratories or manufacturing sites on their own. FDA also says registration or listing does not denote approval. A COA, lab logo, inspection, registration, or listing does not prove FDA approval of an item.
These pages answer narrow questions. They do not rank suppliers or decide a purchase.
Resolve each legal entity and role
Ask for the exact legal name, trade name, address, web domain, and contact route. Then separate the roles.
| Role | Question |
|---|---|
| Seller | Who invoices the buyer? |
| Maker | Who makes the item or starting material? |
| Packer | Who fills, seals, or labels it? |
| Trader | Who buys and resells it? |
| Shipper | Who holds and sends it? |
| Lab | Who receives the sample and issues the report? |
| Data owner | Who keeps the raw data and method record? |
Do not merge roles because names look alike. Record the claimed link. Then ask for a contract, issuer record, public record, or direct reply that supports it.
Use an outside contact route when a fact matters. A phone number shown only on the supplier site is not independent. Find the issuer through its official site or registry.
If the maker or lab identity stays hidden, mark it UNKNOWN. Decide whether that gap creates HOLD under the team’s set rule. Do not call it fraud without evidence.
Freeze the item scope
A supplier review needs an exact item boundary. Record the name, form, container, fill, label, supplier SKU, maker code, and intended research sale scope. Add the lot when it exists.
Do not let one reviewed item cover a full catalog by default. A new form, source, maker, container, or label can reopen the review.
Capture each material claim. This can include identity, content, purity, test status, accreditation, registration, approval, storage, or lot specific language. Preserve the exact words and date.
A claim about the business is not the same as a claim about an item. A claim about one sample is not the same as a claim about every unit or future lot.
Request the pre order file
Ask for records before a large or hard to reverse order. Keep each file with a source, received date, version, and hash.
The request can cover:
1. Legal seller and maker identities.
2. Item and container specification.
3. Sample and lot mapping.
4. Current COA or test report.
5. Lab legal name and site.
6. Test methods and criteria.
7. Sampling source and custody.
8. Change notice process.
9. Complaint and return contacts.
10. Record retention and direct verification route.
Ask what is not included. A clean file can still omit sample custody, raw data, method limits, or maker identity.
Map the sample and lot
Follow the identity chain from the item offered to the sample tested.
`offered item to maker item to supplier lot to received lot to lab sample to report`
Each link needs an ID. Compare the lot on the report with the label, order file, pack list, and receipt. Preserve spaces and leading zeros.
Ask who selected the sample. Ask when and where it was taken. Ask who sealed and sent it. A seller chosen sample may be real. Yet it may not represent every unit or later lot.
A generic report can still show a method or example. It cannot prove that the received lot was tested. Mark that link UNKNOWN or CONFLICT.
Verify the lab and scope
Start with the lab name and site shown on the report. Find the lab through the relevant accreditation body or official directory. Do not rely on a logo image.
Check the current certificate, site, status, and scope. The scope should cover the relevant field, method, or test as written. A broad lab status does not place every method inside scope.
The ILAC signatory search finds accreditation bodies. It does not list every report as valid. Contact the relevant body when a certificate or scope is unclear. Contact the lab through an outside route to check the report ID when needed.
Record the answer and date. A match shows the status and scope that were checked. It does not prove the sample source, lot link, result, or item quality.
Read the method and criterion
A result needs a named method and a rule for reading it. Record the method ID, version, instrument class, sample prep, result unit, criterion, and review owner.
Ask who set the criterion. A supplier criterion may be a contract term. A lab may apply a client method. A standard may set another rule. These cases are not the same.
Check whether the method is in the lab’s current scope. Then ask whether it is fit for the item and claim. Scope and method fit are separate questions.
Do not convert a single test into proof of all attributes. An identity result does not prove purity. A purity result does not prove content, safety, sterility, or approval.
Check public records with care
Use current official records only for the fact each record can show. A business registry may show an entity and status. An accreditation record may show a lab site and scope. An FDA page may show an agency record within its own program.
Record the query, date, exact name, site, and result. Save a stable copy when allowed. Do not treat no search hit as proof that the entity does not exist. Names and systems can differ.
Do not treat registration, listing, inspection, or warning letter status as a full product finding. Each has its own scope and date. Route unclear legal meaning to qualified counsel.
Compare the received shipment
Paper review does not replace receipt work. At receipt, compare the purchase order, seller, maker, item, lot, count, container, label, seal, and files.
Create a receipt record before stock can be used. Photograph or scan key IDs. Log damage, shortage, label change, and any new file.
If the lot does not match, set HOLD. If the pack or maker changed without notice, set HOLD. Do not choose the value that makes receipt easier.
Link the received lot to the third party tested claim guide when the supplier uses that phrase. The phrase review asks a narrower set of questions about the outside lab, client, sample, method, and result.
Set change notice rules
Ask the supplier to name changes that trigger notice. Include legal entity, maker, site, process, item form, container, lab, method, criterion, pack, and shipping source.
Set the notice route and owner. A change received by sales but not quality can be missed. Use one controlled queue.
When a change arrives, reopen only the affected checks. If the impact is unclear, set HOLD. Keep the old review and reason for the new version.
Use complaints as review input
Link each complaint to the order, item, lot, supplier, maker, and report. Capture what was observed. Do not add a cause that the facts do not show.
Look for repeats by lot, item, maker, lab, method, pack, and issue type. A group can trigger review or HOLD. It does not prove a cause or supplier fault by itself.
Ask the supplier for a written response when needed. Keep the question, files, dates, answer, and open gaps. Close the case with a reason, not just a status.
Review over time
Set a calendar review and event triggers. Recheck current legal identity, key public records, lab status, lab scope, recent reports, lot mapping, changes, receipt gaps, and complaints.
Use a decision record with the scope, owner, sources, findings, unknowns, conflicts, holds, and next check. The action can be continue review, request data, seek expert review, pause spend, or stop relying on one claim.
The action is internal. It is not a public accusation, approval, endorsement, or guarantee.
Test the file with a sample case
Use fake records before the first live review. Start with one seller and one item. Give the seller a trade name and legal name. Make the maker a second entity. Add a lab as a third entity.
Have the seller claim that each lot gets outside testing. Mark that claim ASSERTED. Add a report with a lab name and sample code. Give the report a lot code that does not match the item label.
The expected state is CONFLICT. The item should move to HOLD. The reviewer should save both codes. The next task is a direct check with the supplier and lab.
Now add an accreditation record. Make the lab site match. Make the scope broad but unclear on the named method. The lab status can be VERIFIED. The method scope stays UNKNOWN. The report and item result also stay unproved.
Next, add a corrected report. Tie it to the received lot. Add a direct reply from the lab. The lot link may now move to VERIFIED. Other claims do not change.
Finish with an unannounced maker change. The prior item review should reopen. The new shipment stays on HOLD. This test shows why one pass cannot cover all later lots.
Frequently Asked Questions
Does an accredited lab prove the supplier is good?
No. Accreditation status and scope address the lab within that record. They do not prove the seller, sample, lot link, item result, or future work.
Does an ILAC signatory search prove a report is real?
No. It helps locate the relevant accreditation body. Check the lab, site, scope, and report through the right source.
Does a COA prove FDA approval?
No. FDA says it does not approve labs or sites on their own. A lab report or logo is not an FDA product approval.
What should happen when the lot does not match?
Set HOLD. Preserve the report, label, order, and receipt. Ask the supplier and issuer to resolve the mismatch.
Is one supplier review permanent?
No. Entities, makers, items, labs, methods, records, and results can change. Use both set dates and event based review.
Educational and legal disclaimer
This article is for education only. It is not legal, regulatory, quality, safety, scientific, or medical advice. It gives no human use guidance. It is not a supplier approval, ranking, endorsement, blacklist, or purchase recommendation. It does not guarantee supplier identity, lab status, accreditation, item identity, purity, content, potency, safety, compliance, approval, or trust. Use qualified reviewers for the exact supplier, item, lot, report, place, and facts.
Sources and review record
1. World Health Organization, Model Certificate of Analysis, 2018, accessed August 4, 2026, within its pharmaceutical quality control context.
2. International Laboratory Accreditation Cooperation, Accredited Conformity Assessment Bodies, accessed August 4, 2026.
3. Food and Drug Administration, Is It Really FDA Approved, accessed August 4, 2026.
Evidence cutoff is August 4, 2026. No supplier packet, item file, lab scope, report, sample record, received lot, or complaint file was supplied. Those facts remain UNKNOWN or NOT TESTED.